Location History:
- Manitoba, CA (2014)
- Winnipeg, CA (2009 - 2016)
Company Filing History:
3 out of 832,812 Years Active: 2009-2016
Title: Jody Berry - Innovator in Monoclonal Antibodies
Introduction
Jody Berry is a prominent inventor based in Winnipeg, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 3 patents, her work focuses on innovative solutions for treating infections.
Latest Patents
Jody Berry's latest patents include the characterization and isolation of monoclonal antibodies to anthrax protective antigen. The antibodies, designated as F20G75, F20G76, and F20G77, exhibit neutralizing activities. These monoclonal antibodies can be utilized as a pharmaceutical composition for individuals suspected of or at risk of anthrax infection. They specifically bind to a region comprising amino acids 311-316 of the protective antigen (PA) and a larger fragment comprising amino acids 301-330 of PA. Additionally, vaccines containing these peptides may be employed to immunize individuals against anthrax infection.
Career Highlights
Throughout her career, Jody has worked with various organizations, including Her Majesty the Queen in Right of Canada, as represented by the Minister. Her expertise in monoclonal antibodies has positioned her as a key figure in the biotechnology sector.
Collaborations
Jody has collaborated with notable coworkers such as Mike Gubbins and Raymond Tsang. Their combined efforts have contributed to advancements in the field of immunology and therapeutic development.
Conclusion
Jody Berry's innovative work in monoclonal antibodies showcases her dedication to improving healthcare solutions. Her patents reflect her commitment to addressing critical health challenges, particularly in the realm of infectious diseases.